• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Novo Nordisk’s Ozempic and Wegovy Reshape Denmark’s Economy

Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth.

Eshe Nelson
Author: Eshe Nelson

Written by

Eshe Nelson

in

Denmark, Diabetes, Drugs (Pharmaceuticals), Economic Conditions and Trends, Gross Domestic Product, Novo Nordisk A/S, Ozempic (Drug), Semaglutide (Drug)
←Oliver Anthony Music’s ‘Rich Men North of Richmond’ Stays No. 1
France To Ban Muslim Students From Wearing Abayas In Schools→

More posts

  • WATCH: 2026 Oscars’ big winners, historic moments

  • Before Every Game, Azzi Fudd Does The Same Three Things

  • Micron rises after closing acquisition of PSMC’s Tongluo P5 site, plans to nearly double cleanroom manufacturing space

  • Pick Your Favorite Disney Characters And We’ll Reveal Your Hero-Villain Duo

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube